|
EMPOWER ANNOUNCES ANTICIPATED DELAY IN ANNUAL FILING VANCOUVER B.C.: APRIL 26, 2019 – EMPOWER CLINICS INC. (CSE: CBDT) (Frankfurt 8EC) (“Empower” or the “Company”), today announced it anticipates a delay in filing its audited annual financial statements for the year ended December 31, 2018, and the related management’s discussion and analysis and certificates of its CEO and CFO (collectively, the “Required Filings”) with Canadian securities regulators until after the April 30, 2019 filing deadline. The additional time is required to permit the Company’s auditors, MNP LLP, to complete their review and enquiries in connection with the audit of the Company’s 2018 financial statements. The Company and its auditors are working diligently, and the Company intends to make the Required Filings as soon as possible and by no later than May 15, 2019. In connection with this anticipated delay, the Company has applied to the Ontario Securities Commission, the Company’s principal regulator in Canada, for a customary management cease trade order (the “MCTO”) relating to trading in the Company's securities by the Company’s CEO and CFO. There is no guarantee that the MCTO will be granted. If granted, the MCTO should not affect the ability of other shareholders to trade in the securities of the Company. If the MCTO is granted, the Company intends to comply with the provisions of the alternative information guidelines set out in National Policy 12-203 Management Cease Trade Orders (“NP 12-203”) by providing bi-weekly updates by way of news release until the Required Filings have been made. ABOUT EMPOWER Empower is a leading multi-state operator (MSO) of a network of physician-staffed clinics focused on helping patients improve and protect their health through innovative physician recommended treatment options. With over 120,000 patients, an expanding clinic footprint, a focus on new technologies, including tele-medicine, and an expanded product development strategy, Empower is undertaking new growth initiatives to be positioned as a vertically integrated, diverse, market-leading service provider for complex patient requirements in 2019 and beyond. The Company has announced its intention to build a hemp-based CBD extraction facility in Portland, OR commencing in Q2 2019. ON BEHALF OF THE BOARD OF DIRECTORS: Steven McAuley Chief Executive Officer CONTACTS: Investors: Steve Low Boom Capital Markets 647-620-5101 For French inquiries: Remy Scalabrini, Maricom Inc., E: rs@maricom.ca, T: (888) 585-6274 Investors:Steven McAuley CEO s.mcauley@empowerclinics.com 604-789-2146 |
|
| aus der Diskussion: | Empower Clinics weltweit erste Cannabis Klinik |
| Autor (Datum des Eintrages): | reniarB. (27.04.19 10:46:43) |
| Beitrag: | 120 von 6,034 (ID:60437277) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |